InnoBiotech is at the forefront of the drug development process in oncology, to deliver pioneering and affordable drugs across the commonest and deadliest cancers.
InnoBiotech is focused on developing a robust industry leading pipeline of best-in-class and first-in-class antibody therapies, leveraging InnoBiotech's proprietary antibody discovery technology that delivers unprecedented success rates in the discovery of functional antibodies to various targets. It is built on a deep understanding of immunology and antibody production enabling us to discover functional antibodies to complex protein targets.